Effects of leptin on arcuate pro-opiomelanocortin and cocaine-amphetamine-regulated transcript expression are independent of circulating levels of corticosterone

Journal of Neuroendocrinology

Volumn 14, Issue 11, 2002, Pages 880-886

  Vrang, N ^a   Kristensen, P ^b   Tang Christensen, M ^a   Larsen, P J ^a  

^a Rheoscience ^*  (Denmark)

^b Inoxell   (Denmark)

Author keywords

Adrenalectomy; Arcuate nucleus; Feeding; Ob obmice HPA axis

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOSTERONE; GLUCOCORTICOID; MESSENGER RNA; PROOPIOMELANOCORTIN; RECOMBINANT LEPTIN;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BRAIN; CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DATA ANALYSIS; DECAPITATION; FOOD INTAKE; HORMONE DEFICIENCY; HORMONE DETERMINATION; MOUSE; NONHUMAN; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ARCUATE NUCLEUS; BODY WEIGHT; CORTICOSTERONE; EATING; HUMANS; IN SITU HYBRIDIZATION; LEPTIN; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PRO-OPIOMELANOCORTIN;

EID: 18744394600     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2002.00855.x     Document Type: Article

References (48)

1. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999; 22: 221-232.
2. Ahima RS. Leptin and the neuroendocrinology of fasting. Front Horm Res 2000; 26: 42-56.
3. Woods SC, Seeley RJ, Porte JRD, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998; 280: 1378-1383.
4. Håkansson M-L, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998; 18: 559-572.
5. Elmquist JK, Bjørbæk C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998; 395: 535-547.
6. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996; 387: 113-116.
7. Tang-Christensen M, Holst JJ, Hartmann B, Vrang N. The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport 1999; 10: 1183-1187.
8. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 1997; 273: E202-E206.
9. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.
10. Huszar D, Lynch CA, Fairchild-Huntress V, Fang Q, Berkemeier JH, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
11. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, van Thiele TEDG, Baskin DG, Schwartz MW. Melanocortin receptors in leptin effects. Nature 1997; 390: 349.
12. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998; 393: 72-76.
13. Larsen PJ, Vrang N, Petersen P-C, Kristensen P. Chronic intracerbroventricular administration of recombinant CART (42-89) peptide inhibits food intake and causes weight loss in lean and Zucker (fa/fa) obese rats. Obes Res 2000; 8: 590-596.
14. Vrang N, Tang-Christensen M, Larsen PJ, Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res 1999; 818: 499-509.
15. Vrang N, Larsen PJ, Kristensen P, Tang-Christensen M. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 2000; 141: 794-801.
16. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 1998; 29: 1-6.
17. Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF, Hsiung HM, Koster A. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 2001; 142: 4394-4400.
18. del Giudice EM, Santoro N, Cirillo G, D'Urso L, Di Toro R, Perrone L. Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 2001; 50: 2157-2160.
19. Bray GA, Fisler JS, York DA. Neuroendocrine control of the development of obesity: understanding gained from studies of experimental animal models. Front Neuroendocrinol 1990; 11: 128-181.
20. King BM. Glucocorticoids and hypothalamic obesity 3. Neurosci Biobehav Rev 1988; 12: 29-37.
21. De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995; 270: 15958-15961.
22. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J. Bue-Valleskey J, Stephens TW. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996; 271: 5301-5304.
23. Boston BA, Blaydon KM, Varnerin J, Cone RD. Independent and additive effects of central POMC and leptin pathways on murin obesity. Science 1997; 278: 1641-1644.
24. Zakrzewska KE, Cusin I, Sainsbury A, Rohner JF, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997; 46: 717-719.
25. Fuxe K, Wikström A-C, Okret S, Agnati LF, Härfstrand AYuZ-Y, Granholm S, Zoli M, Vale W, Gustafsson J-A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985; 117: 1803-1812.
26. Cintra A, Bortolotti F. Presence of strong glucocorticoid receptor immunoreactivity within hypothalamic and hypophyseal cells containing pro-opiomelanocortic peptides. Brain Res 1992; 577: 127-133.
27. Kristensen P, Eriksen J, Dano K. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 1991; 39: 341-349.
28. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997; 46: 2119-2123.
29. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV. Hyopthalamic Pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998; 47: 294-297.
30. Korner J, Chou SC, Williams JA, Leibel RL, Wardlaw SL. Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats. Neuroendocrinology 1999; 70: 377-383.
31. Beaulieu S, Gagne B, Barden N. Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus Mol Endocrinol 1988; 2: 727-731.
32. Pelletier G. Regulation of proopiomelanocortin gene expression in rat brain and pituitary as studied by in situ hybridization. Ann NY Acad Sci 1993; 680: 246-259.
33. Wardlaw SL, McCarthy KC, Conwell IM. Glucocorticoid regulation of hypothalamic proopiomelanocortin. Neuroendocrinology 1998; 67: 51-57.
34. Scanlon MN, Lazar-Wesley E, Csikos T, Kunos G. Rat hypothalamic proopiomelanocortin messenger RNA is unaffected by adrenalectomy. Biochem Biophys Res Common 1992; 186: 418-425.
35. Birnberg NC, Lissitzky JC, Hinman M, Herbert E. Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion. Proc Natl Acad Sci USA 1983; 80: 6982-6986.
36. Arvaniti K, Huang Q, Richard D. Effects of leptin and corticosterone on the expression of corticotropin-releasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse. Neuroendocrinology 2001; 73: 227-236.
37. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK. Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997; 82: 1635-1637.
38. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996; 45: 1435-1438.
39. Murakami T, Iida M, Shima K. Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 1995; 214: 1260-1267.
40. Stephens TW, Basmski M, Bristow P, Bue-Valleskey JM, Burgett SG, Craft C, Hale J, Hoffmann J, Hslung HM, Kriauciunas A, MacKellar W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang XY, Helman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-533.
41. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS, Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997; 99: 391-395.
42. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress, Endocrinology 1997; 138: 3859-3863.
43. Huang Q, Rivest R, Richard D. Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 1998; 139: 1524-1532.
44. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101-1106.
45. van Dijk G, Seeley RJ, Thiele TE, Friedman MI, Ji H, Wilkinson CW, Burn P, Campfield LA, Tenenbaum R, Baskin DG, Woods SC, Schwartz MW. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat. Am J Physiol 1999; 276: R1425-RI433.
46. Ahima RS, Prabakaran D, Flier JS. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest 1998; 101: 1020-1027.
47. Dallman MF, Struck AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Frontiers Neuroendocrinol 1993; 14: 303-345.
48. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Med 1997; 3: 575-579.